The clinical problem

Most people have no real baseline. They have scattered lab values from different years, a sense of how they feel, and very little that maps where their health is actually heading. You cannot modify a trajectory you have never measured.

The UroLongevity approach

The comprehensive evaluation builds that missing baseline in one coordinated process. It is the foundation the entire framework rests on — the diagnostics-and-monitoring tier described in How We Work. The aim is a picture complete enough that every subsequent decision is grounded in your data, not in averages.

◆ Dr. Shusterman’s take

A baseline is not a luxury. It is the difference between practicing medicine on you and practicing medicine on a population average that may not resemble you at all.

What’s involved

At a high level, evaluation and intervention may include:

  • Advanced laboratory work — metabolic, inflammatory, and organ-function markers beyond a standard panel
  • Advanced urine analysis — the urological window onto real-time metabolic and renal function
  • Cardiovascular markers — advanced lipids and risk markers; imaging where indicated
  • Body composition — lean mass, fat distribution, and metabolic correlates
  • Functional measures — relevant measures of physical capacity
  • Cognitive baselining — an early reference point for cognitive trajectory
  • A structured review consultation — where the data becomes a plan you understand
On dosing Specific dosing and protocols are individualized to your clinical picture and decided in consultation. They are not published here, because one-size guidance is not good medicine.

Honest expectations

The evaluation produces clarity, not certainty. It will show strengths, risks, and a baseline against which future change is measured. It will not predict the future precisely, and some findings will warrant watchful monitoring rather than immediate action. That, too, is a result worth having.